Monthly Archives: January 2010

ISO: Biotech Humanitarian

We are looking for biotech humanitarians for our annual Biotech Humanitarian Award. The award recognizes an everyday hero who has helped to heal, fuel or feed the planet through their work in biotechnology. Know someone that you feel should be recognized for their good works? Nominate someone at www.iambiotech.org/award through January 31, 2010. 2009 Biotech Humanitarian Dr. Jay Keasling, was nominated by a colleague at the University of California at Berkley. Just think, you or Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post

ISO: Biotech Humanitarian

We are looking for biotech humanitarians for our annual Biotech Humanitarian Award. The award recognizes an everyday hero who has helped to heal, fuel or feed the planet through their work in biotechnology. Know someone that you feel should be recognized for their good works? Nominate someone at www.iambiotech.org/award through January 31, 2010. 2009 Biotech Humanitarian Dr. Jay Keasling, was nominated by a colleague at the University of California at Berkley. Just think, you or your Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

Risk/Reward Favored Small & Micro Caps in 2009

For US biotechs in 2009, the smaller the company’s market capitalization, the higher the return…

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: ,

DOE Awards Grants to Biofuel, Chemical Biorefineries

Last month, Energy Secretary Steven Chu and Agriculture Secretary Tom Vilsack announced 19 biomass projects that would receive renewable energy grants under the American Recovery and Reinvestment Act. The list included 14 pilot, 4 demonstration, and 1 commercial-scale project, receiving a total of $561 million in grants ranging in size from $2.5 million to $81 million. The projects will be located in 15 different states. Additionally, Vilsack announced a $54.5 million Biorefinery Assistance Program loan guarantee Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

2009 – A Big Year for the BTK

The Amex Biotech Index, the BTK, outpaced its peer, the Nasdaq Biotech Index, by 29% and was 22% above the SP500.   Most of this can be attributed to 3rd quarter performance when Human Genome Sciences (HGSI) released P3 data for their antibody drug for Lupus. HGSI gained 555% in 3Q09, and the impact on the 20 company BTK can be seen in the lower bar chart. * *It should be noted that both major Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,